Loading
TI
TESARO, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by NEW ENTERPRISE ASSOCIATES 13 LP, was filed 06 Mar 2018.
TESARO, Inc.: what insiders have been doing
Every trade that managers of TESARO, Inc. disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of TESARO, Inc. in twelve months, the latest record being from 24 January 2019.
Our records for TESARO, Inc. go back to 2016, with 123 purchases and 50 sales on the open market in total.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
302
Thresholds
n/a
Buy Volume
€298M
123 ops. · all time
Sell Volume
€15M
50 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Revenue199.1M
Net income-442.2M-222.2% margin
Last declaration on 24 January 2019
Declarations302 total
45,907 shares@ US$75.002.1% of flowCommon StockSEC:0001123292-19-000190:0
1,994,768 shares@ US$75.0089.8% of flowCommon StockSEC:0001123292-19-000190:1
168,755 shares@ US$75.007.6% of flowCommon StockSEC:0001123292-19-000190:2
10,998 shares@ US$75.000.5% of flowCommon StockSEC:0001123292-19-000190:3
868 shares@ US$75.000.0% of flowCommon StockSEC:0001123292-19-000190:4
9,681,038 shares@ US$75.0099.2% of flowCommon StockSEC:0001209191-19-004682:0
15,362 shares@ US$75.000.1% of flowCommon StockSEC:0001209191-19-004681:0
9,681,038 shares@ US$75.0091.8% of flowCommon StockSEC:0001209191-19-004681:1
1,333 shares@ US$75.000.0% of flowCommon StockSEC:0001209191-19-004681:3
4,977 shares@ US$75.0080.1% of flowCommon StockSEC:0001123292-19-000163:0
12,206 shares@ US$75.0089.7% of flowCommon StockSEC:0001123292-19-000168:0
1,671 shares@ US$75.00100.0% of flowCommon StockSEC:0001123292-19-000170:0
6,211 shares@ US$75.0078.1% of flowCommon StockSEC:0001123292-19-000173:0
29,378 shares@ US$75.0025.1% of flowCommon StockSEC:0001123292-19-000171:0
9,681,038 shares@ US$75.0092.0% of flowCommon StockSEC:0001209191-19-004683:0
739,517 shares@ US$75.007.0% of flowCommon StockSEC:0001209191-19-004683:1
767 shares@ US$75.000.0% of flowCommon StockSEC:0001209191-19-004683:2
9,367 shares@ US$75.0083.4% of flowCommon StockSEC:0001123292-19-000166:0
2,156 shares@ US$75.0071.1% of flowCommon StockSEC:0001123292-19-000165:0
9,681,038 shares@ US$75.0099.1% of flowCommon StockSEC:0001209191-19-004685:0
1,333 shares@ US$75.000.0% of flowCommon StockSEC:0001209191-19-004685:1
2,757 shares@ US$75.00100.0% of flowCommon StockSEC:0001123292-19-000172:0
1,279 shares@ US$75.00100.0% of flowCommon StockSEC:0001123292-19-000174:0
1,500 shares@ US$75.00100.0% of flowCommon StockSEC:0001123292-19-000162:0
2,090 shares@ US$75.00100.0% of flowCommon StockSEC:0001123292-19-000164:0
25 of 302 declarations
About TESARO, Inc.
TESARO, Inc. is a biopharmaceutical company focused on developing treatments for cancer patients. It emphasizes innovation in the oncology field.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
